These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38275834)

  • 1. Primary Diffuse Leptomeningeal Melanomatosis in a Child with Extracranial Metastasis: Case Report.
    Shahab SW; Patil P; Fangusaro JR; Patteson B; Goldman-Yassen A; Eaton BR; Boydston W; Schniederjan M; Aguilera D
    Curr Oncol; 2024 Jan; 31(1):579-587. PubMed ID: 38275834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system malignant melanoma with leptomeningeal melanomatosis: a case report and review of the literature.
    Fujimori K; Sakai K; Higashiyama F; Oya F; Maejima T; Miyake T
    Neurosurg Rev; 2018 Jan; 41(1):333-339. PubMed ID: 28986666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
    Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
    BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic challenges of primary diffuse leptomeningeal melanomatosis in early adolescence: A case report.
    Yamauhci S; Fukuyama T; Inaba Y; Nakajima H; Hattori Y; Miyairi Y; Ogiso Y
    Brain Dev; 2022 Jun; 44(6):421-425. PubMed ID: 35260265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated
    Ascierto PA; Mandalà M; Ferrucci PF; Guidoboni M; Rutkowski P; Ferraresi V; Arance A; Guida M; Maiello E; Gogas H; Richtig E; Fierro MT; Lebbè C; Helgadottir H; Queirolo P; Spagnolo F; Tucci M; Del Vecchio M; Gonzales Cao M; Minisini AM; De Placido S; Sanmamed MF; Mallardo D; Curvietto M; Melero I; Palmieri G; Grimaldi AM; Giannarelli D; Dummer R; Chiarion Sileni V
    J Clin Oncol; 2023 Jan; 41(2):212-221. PubMed ID: 36049147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Diffuse Leptomeningeal Melanomatosis in an Indian Child With Review of Literature.
    Kumar A; Gunasekaran PK; Aggarwal D; Janu V; Manjunathan S; Laxmi V; Tiwari S; Saini L
    Pediatr Neurol; 2024 Mar; 152():23-29. PubMed ID: 38176225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary diffuse meningeal melanomatosis. Case report].
    Bajer-Czajkowska A; Nowacki P
    Neurol Neurochir Pol; 2007; 41(1):82-8. PubMed ID: 17330185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary diffuse meningeal melanomatosis: radiologic-pathologic correlation.
    Pirini MG; Mascalchi M; Salvi F; Tassinari CA; Zanella L; Bacchini P; Bertoni F; D'Errico A; Corti B; Grigioni WF
    AJNR Am J Neuroradiol; 2003 Jan; 24(1):115-8. PubMed ID: 12533338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRAS
    Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
    Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric primary diffuse leptomeningeal melanomatosis: Case report and review of the literature.
    Xu X; Zheng Y; Li J; Wang F; Li F
    Medicine (Baltimore); 2020 Feb; 99(8):e19178. PubMed ID: 32080099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal Melanomatosis.
    Baumgartner A; Stepien N; Mayr L; Madlener S; Dorfer C; Schmook MT; Traub-Weidinger T; Lötsch-Gojo D; Kirchhofer D; Reisinger D; Hedrich C; Arshad S; Irschik S; Boztug H; Engstler G; Bernkopf M; Rifatbegovic F; Höller C; Slavc I; Berger W; Müllauer L; Haberler C; Azizi AA; Peyrl A; Gojo J
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33921303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
    Afzal MZ; Mabaera R; Shirai K
    J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES).
    Lau PKH; Feran B; Smith L; Lasocki A; Molania R; Smith K; Weppler A; Angel C; Kee D; Bhave P; Lee B; Young RJ; Iravani A; Yeang HA; Vergara IA; Kok D; Drummond K; Neeson PJ; Sheppard KE; Papenfuss T; Solomon BJ; Sandhu S; McArthur GA
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34625515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary leptomeningeal melanomatosis: early leptomeningeal enhancement on MRI.
    Celli P; Acqui M; Trillò G; Ramundo EO; D'Andrea G; Roperto R; Ferrante L
    J Neurosurg Sci; 2001 Dec; 45(4):235-40. PubMed ID: 11912478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Diffuse Leptomeningeal Melanomatosis: Case Report and Review of the Literature.
    Eichberg DG; Achua JK; Locatelli E; Shah AH; Komotar RJ; Ghods AJ
    World Neurosurg; 2019 Feb; 122():648-655. PubMed ID: 30496931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant Transformation and Leptomeningeal Melanomatosis in a Primary Meningeal Melanocytoma: A Case Report and Review of Literature.
    Nakase K; Matsuda R; Okamoto T; Nakagawa I; Takeda M; Sakata K; Nakase H
    NMC Case Rep J; 2023; 10():315-320. PubMed ID: 38076394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary diffuse meningeal melanomatosis - a rare form of meningeal melanoma: case report.
    Garbacz T; Osuchowski M; Bartosik-Psujek H
    BMC Neurol; 2019 Nov; 19(1):271. PubMed ID: 31690266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of BRAF/MEK inhibitor-resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity-modulated radiotherapy.
    Okuma T; Furudate S; Kambayashi Y; Hashimoto A; Aiba S; Fujimura T
    J Dermatol; 2021 Sep; 48(9):1419-1422. PubMed ID: 34002878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab.
    Palacka P; Slopovsky J; Makovnik M; Kajo K; Obertova J; Mego M
    Medicine (Baltimore); 2022 Jan; 101(3):e28613. PubMed ID: 35060532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
    Tawbi HA; Forsyth PA; Algazi A; Hamid O; Hodi FS; Moschos SJ; Khushalani NI; Lewis K; Lao CD; Postow MA; Atkins MB; Ernstoff MS; Reardon DA; Puzanov I; Kudchadkar RR; Thomas RP; Tarhini A; Pavlick AC; Jiang J; Avila A; Demelo S; Margolin K
    N Engl J Med; 2018 Aug; 379(8):722-730. PubMed ID: 30134131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.